Obstetrics/Gynecology
How to Predict Success for IVF
October 3, 2010 8:33 pm | by Massachusetts Institute of Technology | News | CommentsA new technique can determine which fertilized eggs will reach a crucial step in development.
Manu Platt Wins $1.5M NIH Director's New Innovator Award
October 1, 2010 6:32 am | by Georgia Tech Institute of Technology | News | CommentsManu Platt from the biomedical engineering department at Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease.
South Carolina Optometrists Partner with State Legislators and Local Mayors in Improving Infant Eye and Vision Care
September 20, 2010 6:31 am | by Bio-Medicine.Org | News | CommentsCHARLESTON, S.C., Sept. 20 /- Due to the overwhelming number of children with eye and vision problems across the United States, South Carolina optometrists are devoting appointments to no-cost, comprehensive eye and vision assessments for infants between six to 12 months of age through...
HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
September 17, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsPARIS and MORRISTOWN, N.J., Sept. 17 /- HRA Pharma , a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc. (NYSE: WPI ) announced today that they...
Baylor researchers advancing genetic treatment for ovarian cancer
September 16, 2010 1:35 pm | by Baylor College of Medicine | News | CommentsAs the understanding of the biology of ovarian cancer broadens, there is an increased need to develop treatments that are targeted toward a person's genetic makeup, said a clinician-researcher from Baylor College of Medicine. "We have not been able to pinpoint exactly what causes ovarian...
Texting initiative expands to reinforce healthy teen behavior
September 16, 2010 5:32 am | by Baylor College of Medicine | News | CommentsTeens today communicate in a different way than in the past, and physicians and staff at the Baylor Teen Health Clinic are taking advantage of these new communication methods to reach their patients. "Teenagers are more attached to their phones than ever before but they are not...
Acceleron signs lucrative development deal with Shire
September 9, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | News | CommentsAcceleron Pharma Inc. and Shire plc have signed a development and commercialization deal associated with Acceleron’s novel molecules linked to skeletal muscle growth. The agreement will bring in $45 million in upfront payments to Acceleron, along with additional payments of up to $453 million.
Survey Reveals Roughly 3 in 5 Women May be Mistreating Their Yeast Infections
September 9, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsSKILLMAN, N.J., Sept. 9 /- For more information, please go to: http://monistat.presslift.com/yeastinfections . Few women go through life having never suffered from the uncomfortable symptoms of a yeast infection. In fact, nearly 3 in 4 (72 percent) women will experience their first...
Alere and AirStrip Technologies - a Powerful Collaboration Brings Innovative Remote Patient Monitoring to Obstetrical Care
August 26, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsATLANTA, Aug. 26 /- Alere Health, LLC, a leader in personal health support solutions (a division of Alere Inc.) (NYSE: ALR ), today announced a new collaboration with AirStrip Technologies Inc., a pioneer in mobile medical software development. (Logo:...
Preconception counseling helps future moms prep for baby
August 18, 2010 5:37 pm | by Baylor College of Medicine | News | CommentsWhen a couple decides to have a child, it is important for the future mom to be in optimal condition, both physically and emotionally, said a maternal fetal medicine expert from Baylor College of Medicine . "There are a lot of different elements of a woman's health that ideally ought to...
Grants support use of state-of-the-art technology to determine cancer risk
August 18, 2010 5:36 pm | by Baylor College of Medicine | News | CommentsRecent grants to a Baylor College of Medicine geneticist will help fund studies that seek to understand why some children are more at risk for cancer. Dr. Sharon Plon, professor of pediatrics – hematology/oncology, received a $2.1 million grant from the Cancer Prevention and...
BioElectronics Expands Clinical Research in Four Key Categories
August 2, 2010 4:45 am | by The Associated Press | News | CommentsBioElectronics (PINKSHEETS: BIEL) filed four applications for grants in order to conduct clinical studies on Diabetic Neuropathic Foot Ulcers, Oral Surgery Pain, Plantar Fasciitis, and Menstrual Pain. Upon completion of the studies, the data will be used for U.S. FDA submissions to gain...
Encision's Technology Recognized as A Means to Eliminate Surgery Burns
July 28, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsBOULDER, Colo. , July 28 /- Encision Inc. (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, recognized as a technology to eliminate visceral burns during monopolar electrical...
Yale cell researchers win $2.5M grants
July 26, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | News | CommentsTwo Yale University scientists working on cell biology have been named as recipients of the 2010 Pioneer Award from the National Institutes of Health, with each recipient receiving a $2.5 million grant and laboratory support for five years.
Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences
July 14, 2010 9:46 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif. , July 14 /- Viveve, Inc., a women's sexual health company that has developed a medical device and procedure to treat vaginal laxity, recently received notification that its sponsored abstracts were accepted for the 2010 International Meetings for the International...
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestivaâ„¢
July 13, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsST. LOUIS , July 13 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. (Nasdaq: HOLX ) that a resubmission to the FDA's Complete Response action letter received in January 2009...
Galen Advisors Grows Client Base More Than 50%
July 13, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsATLANTA , July 13 /- Galen Advisors, a leading provider of Revenue Cycle Management solutions for physicians, announced today record growth for the first half of 2010. Assaulted by rising costs, reduced reimbursements and political mandates, physicians are turning to Galen for...
Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
July 2, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 2 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock. "We are pleased to add...
Spina bifida topic of monthly genetics series
July 2, 2010 7:32 am | by Baylor College of Medicine | News | CommentsSpina bifida, a birth defect that involves the incomplete development of the spinal cord, will be the topic of discussion in a public forum Wednesday, July 14, at The Health Museum of Houston . The forum will feature Dr. Daryl Scott, assistant professor of molecular and human genetics at...
Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
July 1, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX ) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia 's CRINONE®...
ExAblate® Receives European CE Mark for Treatment of Adenomyosis
June 23, 2010 2:35 am | by RealWire | News | CommentsNon-invasive procedure now available where options were limited; InSightec innovation continues to expand treatment choice in Women's HealthTIRAT CARMEL, Israel (June 23, 2010) -- InSightec Ltd. announced today that its ExAblate® system has received an expanded CE Mark certification...
BCM home nurse program helps young mothers, children
June 22, 2010 5:36 pm | by Baylor College of Medicine | News | CommentsAn innovative program at the Baylor Teen Health Clinic designed to improve the health and well being of young first-time mothers and their children is celebrating its successes since launching nearly two years ago. The Nurse-Family Partnership program offers home-based nurse services to...
Fertility Drugs Contribute Heavily to Multiple Births
June 16, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsMarch of Dimes Concerned About Drugs' Role in Crisis of Prematurity WHITE PLAINS, N.Y. , June 16 /PRNewswire-USNewswire/ -- The widespread use of fertility drugs, not just high-tech laboratory procedures, plays a major role in causing multiple births and contributes to the problem...
Simbionix Welcomes Two New Members to Expand Compay's Medical Education Product Offerings
June 16, 2010 6:39 am | by Bio-Medicine.Org | News | CommentsCLEVELAND, Ohio , June 16, 2010 /- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce that Marc Schwachter M.D ., and Paul DeLuca have joined the...
KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
May 26, 2010 7:39 am | by Bio-Medicine.Org | News | CommentsEXTON, Pa. , May 26 /- Kensey Nash Corporation (Nasdaq: KNSY ), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug...
